title: Introductory remarks.
authors.affiliation: Clinical Pharmacology Unit, Vargas Medical School, Central University of Venezuela, Caracas, Venezuela. manuel.veloscom@gmail.com
authors.forename: Manuel
authors.initials: M
authors.lastname: Velasco
authors.forename: Valmore
authors.initials: V
authors.lastname: Bermúdez
authors.forename: Zafar H
authors.initials: ZH
authors.lastname: Israili
authors.forename: Rafael
authors.initials: R
authors.lastname: Hernández-Hernández
mesh_terms: D000959:Antihypertensive Agents / Q000627:therapeutic use*; D002318:Cardiovascular Diseases / Q000209:etiology / Q000517:prevention & control*; D003924:Diabetes Mellitus, Type 2 / Q000150:complications / Q000188:drug therapy; D050171:Dyslipidemias / Q000150:complications / Q000188:drug therapy; D006801:Humans; D006973:Hypertension / Q000150:complications* / Q000628:therapy; D012307:Risk Factors
chemical_list: D000959:Antihypertensive Agents